James Lillard to Adjuvants, Immunologic
This is a "connection" page, showing publications James Lillard has written about Adjuvants, Immunologic.
Connection Strength
0.834
-
Singh UP, Singh S, Ravichandran P, Taub DD, Lillard JW. Viral macrophage-inflammatory protein-II: a viral chemokine that differentially affects adaptive mucosal immunity compared with its mammalian counterparts. J Immunol. 2004 Nov 01; 173(9):5509-16.
Score: 0.242
-
Lillard JW, Boyaka PN, Taub DD, McGhee JR. RANTES potentiates antigen-specific mucosal immune responses. J Immunol. 2001 Jan 01; 166(1):162-9.
Score: 0.185
-
Lillard JW, Boyaka PN, Hedrick JA, Zlotnik A, McGhee JR. Lymphotactin acts as an innate mucosal adjuvant. J Immunol. 1999 Feb 15; 162(4):1959-65.
Score: 0.163
-
Lillard JW, McGhee JR. Adjuvants or live delivery systems for the characterization of mucosal T helper subset responses. Res Immunol. 1997 Oct-Dec; 148(8-9):520-7.
Score: 0.148
-
Singh UP, Singh S, Iqbal N, Weaver CT, McGhee JR, Lillard JW. IFN-gamma-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res. 2003 Oct; 23(10):591-600.
Score: 0.056
-
Boyaka PN, Lillard JW, McGhee J. Interleukin 12 and innate molecules for enhanced mucosal immunity. Immunol Res. 1999; 20(3):207-17.
Score: 0.040